跳至主要内容
临床试验/JPRN-UMIN000008075
JPRN-UMIN000008075招募中未知

Efficacy of rosuvastatin for the treatment of Non-alcoholic fatty liver disease with hyperlipidemia - effect of rosvastatin in patients with NAFLD

Juntendo University School of Medicine0 个研究点目标入组 25 人开始时间: 2012年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with hypersensitivity to HMG-CoA reductase inhibitor (statin) 2) Uncontrolled diabetes 3) Viral or autoimmune liver disease 4) Patients with severe liver dysfunction(ALT or AST > 100 IU/L or total bilirubin > 2.5 mg/dL or ALB < 3.5g/dl or PT < 70% or PLT < 100,000/ul) 5) Patients with renal dysfunction (the serum creatinine more than 2.0 mg/dL or Ccr<30mL/min/1.73mm) 6) Patients on treatment with cyclosporine 7) Pregnant and potential pregnancy 8) Patients with hypothyroidism, hereditary myopathy (muscular dystrophy) or family history of hereditary myopathy, and drug-induced myopathy 9) Patients with drug abuse or alcoholism 10) Patients who are ineligible for any other reason in the opinion of the investigator

研究者

发起方
Juntendo University School of Medicine

相似试验